VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > NEWS release

<< Previous

Bullboard Posts

Next >>

Post by salstockpickzon Feb 25, 2021 12:09am

299 Views

Post# 32655290

NEWS release

"The shares will be issued at a deemed price of $.24per share. Two directors of the Company will receive a total of 30,186 common shares in final payment of $7,245.88 of interest on their debentures."

this is good news!!! DR.adams is willing to pay the debt for .24 a share lets gooooooo

ps. bashers show up before big traction (IMO)
gl,

longs

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale